A practical memo for scale-up builders and public decision-makers: what China is optimizing, why it matters, and which EU instruments close the gap.
Key idea: China is not trying to “win research”. It is building an industrialisation machine that compresses the path from lab results to deployable systems. China’s advantage is time-to-TRL, not just time-to-funding: policy + labs + deployment markets push technologies into TRL 5–8 before or right after spin-out. Patents: China leads in volume; international patent families (IPFs) provide a “global competitiveness” filter. Communication is strongest; computing is rising. Clusters matter: Hefei acts like a quantum venture factory (USTC + national lab + industrial spin-outs). Near-term policy direction: the next planning cycle is widely expected to emphasize industrial pilots, “application scenarios”, and diffusion beyond labs. EU implication: Europe needs a coherent instrument stack: PoC grants + university venture funds + testbeds + procurement + scale-up capital.